News Releases

Month Year

Su	Mo	Tu	We	Th	Fr	Sa
25	26	27	28	29	30	1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31	1	2	3	4	5

Cancel Go

Month Year

Su	Mo	Tu	We	Th	Fr	Sa
25	26	27	28	29	30	1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31	1	2	3	4	5

Cancel Go

Email Alerts

Year All Years 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 Keywords Go

Advanced Search

Keywords

  Search Headlines Only

From

To

Asset Types

 Photos  Video  Audio  Documents  Events  Standard

 Basic Search

• Nov 7, 2024

  Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
• Nov 6, 2024

  Insmed To Present at November 2024 Investor Conferences
• Oct 31, 2024

  Insmed Reports Third-Quarter 2024 Financial Results and Provides Business Update
• Oct 24, 2024

  Insmed Ranks No. 1 on Science's 2024 Top Biopharma Employers List
• Oct 23, 2024

  Insmed Unites Across Communities Around the World During Third Annual Global Day of Good
• Oct 17, 2024

  Insmed to Host Third-Quarter 2024 Financial Results Conference Call on Thursday, October 31, 2024
• Oct 8, 2024

  New Subgroup Analyses from Landmark Phase 3 ASPEN Study of Brensocatib in Patients with Bronchiectasis Demonstrate Consistency with Positive Overall Trial Population Results
• Oct 4, 2024

  Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
• Sep 6, 2024

  Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
• Aug 8, 2024

  Insmed Reports Second-Quarter 2024 Financial Results and Provides Business Update

Show 5102550100 per page

Stay In The Loop

Want to stay up to date on our news, events, and filings? Set up your
email alerts.

Sign Up

View the latest Insmed Investor Presentation

Download